Data from bioinformatics analyses, HCC cells, and clinical specimens were combined to describe the novel mechanisms by which glutamyl-prolyl-tRNA synthetase 1 (EPRS1) promotes the synthesis of several downstream proteins and the progression of liver cancer. This evidence concerns the gene EPRS1 and hepatocellular carcinoma.